Antibiotic Rifampicin Shows Promise For Fighting Parkinson’s Disease In Laboratory Tests

Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson’s disease. The drug also dissolved existing fibrils in laboratory tests.
http://www.sciencedaily.com/releases/2004/11/041130235031.htm